Men with prostate cancer are being denied NHS access to a treatment used by Lord Cameron, a senior doctor has revealed.

Two enzymes from the protein disulphide isomerase (PDI) family enable prostate cancer cells to grow, survive, and resist treatment. This discovery, however, could be taken as an advantage to improve ...

The average age of men who get diagnosed is 67.

Of all the health conditions facing men as they get older, there is no doubt that prostate cancer is the most widely ...

Secondary Cancers After NSCLC: What’s the Risk? Among survivors of non-small cell lung cancer, nearly 8% developed non-lung secondary cancers over about 6 years, and this risk may be driven by genetic ...

Secondary Cancers After NSCLC: What’s the Risk? Among survivors of non-small cell lung cancer, nearly 8% developed non-lung secondary cancers over about 6 years, and this risk may be driven by genetic ...

A prostate cancer committee has been accused of exaggerating the risks of screening. Advisers to Wes Streeting, the Health Secretary, rejected calls to offer targeted testing in November, arguing that ...

The thing that struck me hardest about prostate cancer wasn’t the diagnosis, it was the silence. Breast cancer, rightly, ...

The Prostate Clinic (TPC) Lagos, led by Professor Kingsley Ekwueme, has pioneered High-intensity Focused Ultrasound (HIFU) for prostate cancer treatment, positioning Nigeria as the first nation in ...